Cutaneous manifestations of early human immunodeficiency virus exposure

Robert Berger, M. F. Stoner, E. R. Hobbs, T. J. Hayes, R. N. Boswell

Research output: Contribution to journalArticle

Abstract

After demonstrating antibodies to the human immunodeficiency virus (HIV) two hundred patients were interviewed and given a complete cutaneous and mucous membrane examination. By means of the Walter Reed Staging Classification System for HIV infection, 155 patients were classified as having Walter Reed stage 1A-2A (WR1A-WR2A) infection. The prevalence of seborrheic dermatitis in this group was 36%. There were no other significant cutaneous findings in the WR1A-WR2A patient population.

Original languageEnglish (US)
Pages (from-to)298-302
Number of pages5
JournalJournal of the American Academy of Dermatology
Volume19
Issue number2 I
StatePublished - 1988
Externally publishedYes

Fingerprint

Skin Manifestations
HIV
Seborrheic Dermatitis
Skin
Virus Diseases
Mucous Membrane
Antibodies
Infection
Population

ASJC Scopus subject areas

  • Dermatology

Cite this

Berger, R., Stoner, M. F., Hobbs, E. R., Hayes, T. J., & Boswell, R. N. (1988). Cutaneous manifestations of early human immunodeficiency virus exposure. Journal of the American Academy of Dermatology, 19(2 I), 298-302.

Cutaneous manifestations of early human immunodeficiency virus exposure. / Berger, Robert; Stoner, M. F.; Hobbs, E. R.; Hayes, T. J.; Boswell, R. N.

In: Journal of the American Academy of Dermatology, Vol. 19, No. 2 I, 1988, p. 298-302.

Research output: Contribution to journalArticle

Berger, R, Stoner, MF, Hobbs, ER, Hayes, TJ & Boswell, RN 1988, 'Cutaneous manifestations of early human immunodeficiency virus exposure', Journal of the American Academy of Dermatology, vol. 19, no. 2 I, pp. 298-302.
Berger, Robert ; Stoner, M. F. ; Hobbs, E. R. ; Hayes, T. J. ; Boswell, R. N. / Cutaneous manifestations of early human immunodeficiency virus exposure. In: Journal of the American Academy of Dermatology. 1988 ; Vol. 19, No. 2 I. pp. 298-302.
@article{bbdacd4891464b448d4d453329aeccc3,
title = "Cutaneous manifestations of early human immunodeficiency virus exposure",
abstract = "After demonstrating antibodies to the human immunodeficiency virus (HIV) two hundred patients were interviewed and given a complete cutaneous and mucous membrane examination. By means of the Walter Reed Staging Classification System for HIV infection, 155 patients were classified as having Walter Reed stage 1A-2A (WR1A-WR2A) infection. The prevalence of seborrheic dermatitis in this group was 36{\%}. There were no other significant cutaneous findings in the WR1A-WR2A patient population.",
author = "Robert Berger and Stoner, {M. F.} and Hobbs, {E. R.} and Hayes, {T. J.} and Boswell, {R. N.}",
year = "1988",
language = "English (US)",
volume = "19",
pages = "298--302",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 I",

}

TY - JOUR

T1 - Cutaneous manifestations of early human immunodeficiency virus exposure

AU - Berger, Robert

AU - Stoner, M. F.

AU - Hobbs, E. R.

AU - Hayes, T. J.

AU - Boswell, R. N.

PY - 1988

Y1 - 1988

N2 - After demonstrating antibodies to the human immunodeficiency virus (HIV) two hundred patients were interviewed and given a complete cutaneous and mucous membrane examination. By means of the Walter Reed Staging Classification System for HIV infection, 155 patients were classified as having Walter Reed stage 1A-2A (WR1A-WR2A) infection. The prevalence of seborrheic dermatitis in this group was 36%. There were no other significant cutaneous findings in the WR1A-WR2A patient population.

AB - After demonstrating antibodies to the human immunodeficiency virus (HIV) two hundred patients were interviewed and given a complete cutaneous and mucous membrane examination. By means of the Walter Reed Staging Classification System for HIV infection, 155 patients were classified as having Walter Reed stage 1A-2A (WR1A-WR2A) infection. The prevalence of seborrheic dermatitis in this group was 36%. There were no other significant cutaneous findings in the WR1A-WR2A patient population.

UR - http://www.scopus.com/inward/record.url?scp=0023754309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023754309&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 298

EP - 302

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2 I

ER -